Company
Clinical Ink
Clinical ink is leading the way to recenter decentralized clinical trials by connecting data and operations.
Also known as Clinical Ink, Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- sponsors, CROs, and researchers
- Legal name
- Clinical Ink, Inc
- clinicalink.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At the core of our clinical trial solutions is the Clinical ink eSource ecosystem, designed to ingest all incoming data into a unified data platform that supports analytics within and across studies, regardless of how it was captured or by whom.
Funding snapshot
- Total raised
- $21.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.3M2018-05-09
Funding rounds
- Round, 2018
- $5.3M2018-05-09, SEC form D sold, 5 investors
- Round, 2017
- $1.7M2017-12-13, SEC form D sold, 9 investors
- Round, 2015
- $9.9M2015-03-19, SEC form D sold, 21 investors
- Round, 2013
- $1.3M2013-10-15, SEC form D sold, 18 investors
- Round, 2011
- $3.1M2011-11-28, SEC form D sold, 9 investors
- Round, 2010
- $400K2010-07-01, SEC form D sold, 6 investors
Products
- Web
- Clinical ink eSource ecosystem
Loading relationship preview